Spectral Medical Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
EDTXF Over the counter 2834 https://spectraldx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Spectral Medical Inc

Spectral Medical Supports World Sepsis Day - Sep 13th, 2023 11:00 am
Spectral Medical Featured in New Episode of ‘The Balancing Act’ Airing on Lifetime TV Focused on Endotoxic Septic Shock - Sep 8th, 2023 12:13 pm
CORRECTION – Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing - Sep 7th, 2023 5:44 pm
Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing - Sep 7th, 2023 11:00 am
Spectral Medical Inc. Announces Upsizing of Previously Announced Bought Deal Convertible Note Financing to C$5.5M - Aug 22nd, 2023 11:00 am
Spectral Medical Highlights New Episode of ‘The Balancing Act’ Airing on Lifetime TV Focused on Endotoxic Shock - Aug 16th, 2023 3:12 pm
Spectral Medical Announces Second Quarter Results and Provides Corporate Update - Aug 10th, 2023 12:00 pm
Spectral Medical Inc. Announces C$5 Million Bought Deal Convertible Note Financing - Aug 10th, 2023 11:00 am
Spectral Medical Announces Tigris Clinical Trial Update - Jul 25th, 2023 12:00 pm
Investors in Spectral Medical (TSE:EDT) from a year ago are still down 43%, even after 11% gain this past week - Jul 23rd, 2023 1:42 pm
Spectral Medical Announces the Opening of Three Additional Tigris Clinical Trial Sites - Jul 5th, 2023 12:00 pm
Spectral Medical Appoints Former FDA Director, Dr. David W. Feigal, Jr., to Its Board of Directors - Jun 27th, 2023 12:00 pm
Spectral Medical Provides Update on Continued Favorable Tigris Clinical Trial Enrollment - Jun 20th, 2023 12:00 pm
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders - Jun 8th, 2023 8:00 pm
Spectral Medical Provides Update on Favorable Tigris Clinical Trial Enrollment - May 30th, 2023 12:00 pm
Spectral Medical Hosts Successful Investigator Meeting; Expected to Help Bolster Enrollment Activities - May 24th, 2023 12:00 pm
Spectral Medical Announces First Quarter Results and Provides Corporate Update - May 12th, 2023 12:00 pm
Spectral Medical Inc. Announces Director Resignation - May 4th, 2023 8:00 pm
Spectral Medical Announces Positive Results of EUPHAS-2 Clinical Trial Evaluating PMX in Critically Ill Endotoxemic Septic Shock Patients - Apr 18th, 2023 12:00 pm
Spectral Medical Announces Investor Update Conference Call - Apr 6th, 2023 12:00 pm